Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers — Stella

Recruiting

Back to Carrier of Phenylketonuria trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Missouri-Columbia, Columbia, Missouri

Key details

Sponsor

University of Missouri-Columbia

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Enrollment target

~36 participants

Started

December 2025

Primary completion

December 2026

Age range

18 Years – 60 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov